» Articles » PMID: 12805502

Stroke MRI in Intracerebral Hemorrhage: is There a Perihemorrhagic Penumbra?

Overview
Journal Stroke
Date 2003 Jun 14
PMID 12805502
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Cerebral ischemia has been proposed as a contributing mechanism to secondary neuronal injury after intracerebral hemorrhage (ICH). The search for surrogate parameters that allow treatment stratification for spontaneous ICH continues. We sought to assess the presence and prognostic effect of perihemorrhagic ischemic changes and hypoperfusion in a prospective stroke MRI study.

Methods: We performed stroke MRI in 32 patients with hyperacute ICH (mean, 16.9+/-17.2 mL) within 6 hours after symptom onset (mean, 3.1+/-1.3 hours). Clinical data at baseline (National Institutes of Health Stroke Scale) and on day 90 (Barthel Index, modified Rankin Scale) were assessed. Perihemorrhagic perfusion- and diffusion-weighted imaging changes were assessed in a 1-cm-wide area around the clot.

Results: Despite a mild perihemorrhagic mean transit time prolongation of 0.7+/-1.1 second, there were no significant perihemorrhagic apparent diffusion coefficient or mean transit time changes indicating irreversible ischemia or hypoperfusion. ICH size, time to imaging, or clinical severity at baseline or outcome were not reflected by changes of relative apparent diffusion coefficient or perfusion-weighted imaging. ICH size correlated with baseline clinical severity (r=0.51, P=0.005). There was a significant association (P=0.0494) and a significant negative correlation (r=-0.468, P=0.0103) of perihemorrhagic perfusion change with time from symptom onset not associated with ICH size.

Conclusions: Perihemorrhagic hypoperfusion probably is a consequence of reduced metabolic demand (diaschisis) rather than a sign of ischemia. We found no evidence for a perihemorrhagic and potentially salvageable ischemic penumbra in hyperacute ICH. Further studies should address metabolic, toxic, apoptotic, and microvascular aspects.

Citing Articles

Perihematomal oligemia is associated with progression to ischemia and poor outcome in a subset of patients with intracerebral hemorrhage.

Fainardi E, Busto G, Bernardoni A, Padovani A, Casetta I, Morotti A Eur Radiol. 2024; 35(3):1255-1264.

PMID: 39630194 DOI: 10.1007/s00330-024-11243-z.


Mechanism and application of immune interventions in intracerebral haemorrhage.

Xu X, Li Y, Chen S, Wu X, Li J, Li G Expert Rev Mol Med. 2024; 26:e22.

PMID: 39375846 PMC: 11488334. DOI: 10.1017/erm.2024.22.


Clinical implications of Peri-hematomal edema microperfusion fraction in intracerebral hemorrhage intravoxel incoherent motion imaging - A pilot study.

Abou Karam G, Tharmaseelan H, Aboian M, Malhotra A, Gilmore E, Falcone G J Stroke Cerebrovasc Dis. 2023; 32(11):107375.

PMID: 37738914 PMC: 10591892. DOI: 10.1016/j.jstrokecerebrovasdis.2023.107375.


Molecular, Pathological, Clinical, and Therapeutic Aspects of Perihematomal Edema in Different Stages of Intracerebral Hemorrhage.

Jiang C, Guo H, Zhang Z, Wang Y, Liu S, Lai J Oxid Med Cell Longev. 2022; 2022:3948921.

PMID: 36164392 PMC: 9509250. DOI: 10.1155/2022/3948921.


Assessing the Evolution of Intracranial Hematomas by using Animal Models: A Review of the Progress and the Challenges.

Chen Y, Chang J, Wei J, Feng M, Wang R Metab Brain Dis. 2021; 36(8):2205-2214.

PMID: 34417943 DOI: 10.1007/s11011-021-00828-y.